Douglas W. Kingma
- Oncology top 1%
- Pathology and Forensic Medicine top 0.5%
- Immunology top 2%
- Epidemiology top 5%
- Hematology top 2%
- Co-authors
- Elaine S. JaffeMark RaffeldJulie Teruya‐FeldsteinShimareet KumarRobert J. BiggarJames J. GoedertTimothy R. CotéMitchell H. Gail
- Topics
- Lymphoma Diagnosis and Treatment (38 papers)Viral-associated cancers and disorders (31 papers)Eosinophilic Disorders and Syndromes (9 papers)
- Partner nations
- United StatesUnited KingdomHungary
In The Last Decade
Douglas W. Kingma
59 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Oncology 2.4k
- Pathology and Forensic Medicine 1.9k
- Immunology 1.2k
- Epidemiology 777
- Hematology 622
Countries citing papers authored by Douglas W. Kingma
This map shows the geographic impact of Douglas W. Kingma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas W. Kingma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas W. Kingma more than expected).
Fields of papers citing papers by Douglas W. Kingma
This network shows the impact of papers produced by Douglas W. Kingma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas W. Kingma. The network helps show where Douglas W. Kingma may publish in the future.
Co-authorship network of co-authors of Douglas W. Kingma
This figure shows the co-authorship network connecting the top 25 collaborators of Douglas W. Kingma. A scholar is included among the top collaborators of Douglas W. Kingma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas W. Kingma. Douglas W. Kingma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 11 | |
| 3 | 37 | |
| 4 | 98 | |
| 5 | 13 | |
| 6 | 37 | |
| 7 | 25 | |
| 8 | Cytotoxic granular protein expression, Epstein-Barr virus strain type, and latent membrane protein-1 oncogene deletions in nasal T-lymphocyte/natural killer cell lymphomas from Mexico. | 71 |
| 9 | 145 | |
| 10 | Spectrum of AIDS-associated malignant disordersbreakdown → | 539 |
| 11 | 7 | |
| 12 | 20 | |
| 13 | 61 | |
| 14 | 54 | |
| 15 | 94 | |
| 16 | 50 | |
| 17 | 26 | |
| 18 | 11 | |
| 19 | 40 | |
| 20 | 27 |
About Douglas W. Kingma
Douglas W. Kingma is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics, having authored 59 papers that have together received 4.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (38 papers), Viral-associated cancers and disorders (31 papers) and Eosinophilic Disorders and Syndromes (9 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.9k citations), Oncology (2.4k citations) and Immunology (1.2k citations). Douglas W. Kingma has collaborated with scholars based in United States, United Kingdom and Hungary. Frequent co-authors include Elaine S. Jaffe, Mark Raffeld, Julie Teruya‐Feldstein, Shimareet Kumar, Robert J. Biggar, James J. Goedert, Timothy R. Coté, Mitchell H. Gail, Rochelle E. Curtis and Mary M. Horowitz. Their work appears in journals such as New England Journal of Medicine, The Lancet and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.